✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Natco Pharma Ltd.

NATCOPHARM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹14,571 Cr.
P/E
9.47

Natco Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
14,571 Cr
PE
PE
9.47
Prom Holding
Prom Holding
49.48 %
ROE (%)
ROE (%)
24.79
ROCE (%)
ROCE (%)
30.32
Div Yield (%)
Div Yield (%)
0.62
Sales
Sales
4,387 Cr
OPM (%)
OPM (%)
39.59 %
Debt to Equity
Debt to Equity
0.04
View more
Edit Ratio's

About

Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on researc… Read more
Low
727
52W Range
High
1341
  • Natco Pharma
  • Alembic Pharma
  • Jubilant Pharmova
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

12 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.07 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.74 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
16.71 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.56 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
30 %
(as of Mar 19)
Source/Historic
Copaxone - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Therapeutic Area Break-Up - Formulation

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Afinitor
    Aubagio
    Imbruvica
    Kyprolis
    Nexavar
    Pomalyst
    Revlimid
    Sovaldi
    Tarceva
    Tykerb
    Zytiga

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Laurus Labs Ltd.
    • Shaily Engineering Plastics Ltd.
    • Take Solutions Ltd.

    FAQs on Natco Pharma Ltd. Business

    Natco Pharma Limited is a vertically integrated pharmaceutical company that focuses on developing, manufacturing, and marketing pharmaceutical products, along with offering contract manufacturing services and crop health sciences division.

    Natco Pharma major competitors are Alembic Pharma, Jubilant Pharmova, Caplin Point Lab, Eris Lifesciences, Sanofi India, Viyash Scientific, Procter&Gamble Healt.
    Market Cap of Natco Pharma is ₹14,504 Crs.
    While the median market cap of its peers are ₹13,377 Crs.

    Natco Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material